Prime Medicine (PRME)

• Market cap: $729M
• 1 day: -1.46%
• 5 days: -4.94%
• 1 month: 5.76%
• 3 months: 0.75%
• 6 months: 169.33%
• Year to date: 35.12%
• 1 year: 34.67%
• 5 years: -73.72%
• 10 years: -73.72%
• Sector: Healthcare
• Industry: Biotechnology

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214